Beta Bionics, Inc. — Director's Dealing 2025

Jan 31, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-29

Reporting Person: Mensinger Mike (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-29	Employee Stock Option (right to buy)	$17	A	110278	Acquired	2035-01-28	Class B Common Stock (110278)	Direct

Footnotes

F1: Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.

F2: Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.